It’s costlier than other medicine, still the rules about rising and manufacturing are so stringent that most of the growers and brands that have sprung up in Australia are still to make a income. Imports are more affordable. Share prices are tanking.Dozens of trials have begun due to the fact 2016, like higher doses of cannabidiol for spinal cord